United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 6 minute read Pharma Industry News Why addiction treatment companies like Indivior are re-anchoring corporate control in the U.S. Find out why Indivior’s U.S. redomiciliation signals a broader strategic shift across addiction treatment and regulated healthcare companies. bySoujanya RaviJanuary 29, 2026